Survival from cutaneous malignant melanoma is improving, but is it because of a trend in decreasing melanoma thickness or the advent of new 'revolutionary' therapeutics?

Harvima, Ilkka T; Harvima, Rauno J

Harvima, Ilkka T; Harvima, Rauno J.

Afiliação

Harvima IT; Department of Dermatology, University of Eastern Finland and Kuopio University Hospital, Kuopio, Finland.
Harvima RJ; Department of Dermatology, University of Eastern Finland and Kuopio University Hospital, Kuopio, Finland.

Br J Dermatol ; 187(1): 6-7, 2022 07.

Article em En | MEDLINE | ID: mdl-35415923

Assuntos

Melanoma; Neoplasias Cutâneas; Humanos; Melanoma/patologia; Prognóstico; Neoplasias Cutâneas/patologia; Melanoma Maligno Cutâneo

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias Cutâneas / Melanoma Tipo de estudo: Prognostic_studies Limite: Humans Idioma: En Ano de publicação: 2022 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google